Richard Gonzalez, AP Images

Ab­b­Vie puts an end to Botox trade se­crets suit, im­pos­es roy­al­ty, li­cense deal on com­peti­tor Evo­lus

The crown jew­el of Ab­b­Vie’s big-dol­lar ac­qui­si­tion of Al­ler­gan, Botox is one of the most rec­og­niz­able brands in phar­ma — and both drug­mak­ers have worked …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.